Curis to Present at UBS Global Life Science Conference.Business Editors/Health/Medical Writers The UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Global Life Sciences Conference CAMBRIDGE, Ma.--(BUSINESS WIRE)--Sept. 17, 2003 Curis, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CRIS) announced today that Dr. Marc Charette, Vice President of Corporate Communications Corporate communications is the process of facilitating information and knowledge exchanges with internal and key external groups and individuals that have a direct relationship with an enterprise. , will speak at the upcoming UBS Global Life Sciences conference being held at the Plaza Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on September 22-25, 2003. Dr. Charette's presentation is scheduled for 9:30 AM on September 23. He will present an update on Curis' therapeutic product development programs and the company's future plans for partnering. A live audio webcast will be available on the UBS website. You can access the webcast by going to the UBS homepage at www.ibb.ubs.com and clicking on Conferences in the middle of the page. Follow the link for Webcast under the Global Life Sciences Conference heading. The webcast will be archived for thirty days. The UBS Global Life Sciences Conference is held annually and provides a forum for life science companies to meet with investors. It is expected that 350 biotechnology and medical technology companies will present at the conference. About Curis, Inc. Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of kidney disease Kidney Disease Definition Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease. , neurological disorders, cancer, and alopecia alopecia (ăl'əpē`shēə): see baldness. (hair loss). For more information, please visit the Curis web site at www.curis.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion